ECL vs TMO vs CDZI Stock Comparison

Ecolab, Thermo Fisher Scientific and Cadiz Prices as of Nov 13, 2026 Peers: Industry group
ECL Ecolab Inc.
$309.20 +7.4% 1M +18.0% 1Y
Market cap
$87.00B
P/E
41.8x
Revenue (TTM)
$17.37B
Div. yield
0.01%
Water Treatment Industrials
6 wins
CDZI Cadiz Inc
$3.16 -1.9% 1M -34.3% 1Y
Market cap
$259.17M
P/E
–
Revenue (TTM)
$11.84M
Div. yield
–
Water Treatment Industrials
1 win

Head to Head

12 decided of 12

Ecolab leads on 6 of the 12 questions below (Ecolab 6, Thermo Fisher Scientific 5, Cadiz 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionECLTMOCDZILeader
Larger companyMarket capitalisation $87.00B $258.39B $259.17M TMO
Cheaper on earningsLower P/E, profitable companies only 41.8x 36.5x -6.2x TMO
Cheaper on forward earningsLower price / next fiscal year consensus EPS 39.1x 27.0x — TMO
Faster revenue growthRevenue growth, trailing twelve months +9.3% +8.3% -21.3% ECL
More profitableNet margin, trailing twelve months 12.0% 14.9% -353.9% TMO
Better return on capitalReturn on invested capital 10.0% 8.0% -29.0% ECL
Less leveragedLower net debt / EBITDA 4.0x 3.1x -3.3x CDZI
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% ECL
Better 1-year returnPrice return, last 12 months +18.0% +20.7% -34.3% TMO
Better 5-year returnAnnualised price return, 5 years +5.6%/yr +2.0%/yr -11.5%/yr ECL
Less volatileAnnualised volatility, 1 year 21.8% 30.7% 69.5% ECL
Higher overall scoreMean of the five percentile scores vs peers 60/100 60/100 21/100 ECL

Percentile Scorecard

ECLTMOCDZI

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisECLTMOCDZI
Valuation 47 #11 of 20 62 #94 of 243 16 #17 of 20
Growth 82 #4 of 18 41 #136 of 228 47 #10 of 18
Profitability 88 #3 of 17 82 #40 of 222 13 #15 of 17
Financial Health 15 #18 of 21 31 #172 of 248 10 #19 of 21
Shareholder Returns 67 #5 of 13 82 #29 of 158 –
Overall 60 60 21
  • ECL ranked among 21 companies in Environmental Equipment
  • TMO ranked among 252 companies in Medical Devices and Diagnostics
  • CDZI ranked among 21 companies in Environmental Equipment

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodECLTMOCDZISPY
1 month +7.4%+4.0%-1.9% -2.0%
3 months +12.0%+19.1%-8.9% -2.8%
6 months +24.9%+59.7%-23.3% +2.0%
Year to date +17.8%+20.8%-43.7% +10.6%
1 year +18.0%+20.7%-34.3% +12.2%
3 years +68.2%+52.5%+3.3% +68.1%
3 years, per year +18.9%+15.1%+1.1% +18.9%
5 years +31.2%+10.2%-45.8% +61.4%
5 years, per year +5.6%+2.0%-11.5% +10.1%
10 years +167.3%+362.9%-61.5% +248.5%
10 years, per year +10.3%+16.6%-9.1% +13.3%

Risk

MeasureECLTMOCDZISPY
Volatility, 1Y 21.8%30.7%69.5% 13.6%
Downside volatility, 1Y 20.8%29.2%69.5% 13.9%
Beta vs S&P 500, 1Y 0.510.711.56 1.00
Return / volatility, 1Y 0.830.67-0.49 0.90
Max drawdown, 5Y -44.3%-41.5%-72.6% -25.4%
From 52-week high -1.9%-3.0%-54.3% -3.2%
52-week high $315.10$721.63$6.92 $779.14
52-week low $245.73$438.34$2.98 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleECLTMOCDZI
P/E now vs peer median 41.6xmedian 35.2x 36.6xmedian 26.5x -6.3xmedian 35.2x
P/S now vs peer median 5.0xmedian 2.8x 5.5xmedian 2.7x 22.5xmedian 2.8x
EV/EBITDA now vs peer median 32.0xmedian 21.6x 25.5xmedian 18.4x -14.2xmedian 21.6x
P/FCF now vs peer median 48.3xmedian 26.3x 34.2xmedian 25.4x -8.5xmedian 26.3x
P/B now vs peer median 8.3xmedian 2.0x 4.7xmedian 2.5x 57.0xmedian 2.0x
PEG now vs peer median 2.10median 2.10 4.84median 0.98 -0.15median 2.10

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsECLTMOCDZI
Revenue $17.37B $47.35B $11.84M
Gross profit $7.63B $19.45B $3.21M
Operating income $2.90B $8.47B -$27.96M
Net income $2.10B $7.09B -$36.88M
Free cash flow $1.80B $7.60B -$31.27M
R&D – $1.40B –
EPS (diluted) $7.38 $19.06 $-3.88
Cash & equivalents $722.30M $5.46B $5.32M
Total debt $13.19B $41.37B $86.99M
Shares (diluted) 282.10M 371.00M 10.80M
Enterprise value $79.97B $234.90B $224.29M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricECLTMOCDZI
P/E 41.6x 36.6x -6.3x
P/FCF 48.3x 34.2x -8.5x
P/Operating cash flow 28.6x 27.8x -10.2x
P/S 5.0x 5.5x 22.5x
P/B 8.3x 4.7x 57.0x
P/Tangible book 16.2x 7.1x 235.4x
EV/EBITDA 32.0x 25.5x -14.2x
EV/EBIT 34.2x 34.8x -12.4x
EV/Revenue 5.7x 6.2x 29.3x
EV/FCF 55.3x 38.8x -11.1x
EV/Operating cash flow 32.7x 31.6x -13.3x
PEG (3Y EPS CAGR) 2.10 4.84 -0.15

Growth

14 metrics
MetricECLTMOCDZI
Revenue growth (1Y) 9.3% 8.3% -21.3%
Revenue CAGR (3Y) 4.9% 2.9% 77.7%
Gross profit growth (1Y) 8.4% 7.8% -34.0%
Gross profit CAGR (3Y) 8.8% 4.0% 84.8%
Operating income growth (1Y) 11.3% 12.8% -13.2%
Operating income CAGR (3Y) 17.2% 7.2% -13.5%
Net income growth (1Y) 4.7% 7.9% -12.6%
Net income CAGR (3Y) 18.8% 6.2% -5.8%
EPS growth (1Y) 6.2% 9.7% -1.1%
EPS CAGR (3Y) 19.8% 7.6% 42.1%
Operating cash flow growth (1Y) 15.2% 21.9% -57.4%
Operating cash flow CAGR (3Y) 7.8% 4.5% -7.7%
Free cash flow growth (1Y) 15.6% 24.3% -36.8%
Free cash flow CAGR (3Y) 1.8% 5.1% -6.7%

Profitability

14 metrics
MetricECLTMOCDZI
Gross margin 43.9% 41.1% 27.1%
EBITDA margin 17.8% 24.4% -207.0%
Operating margin 16.7% 17.9% -236.1%
Pretax margin 15.0% 16.7% -310.9%
Net margin 12.0% 14.9% -353.9%
FCF margin 10.3% 16.0% -264.0%
Operating cash flow margin 17.4% 19.7% -220.6%
Return on equity 20.4% 13.2% -363.0%
Return on assets 6.9% 6.2% -26.2%
Return on invested capital 10.0% 8.0% -29.0%
Return on capital employed 12.0% 8.5% -21.4%
Asset turnover 0.6x 0.4x 0.1x
Cash conversion (OCF / net income) 1.4x 1.3x 0.7x
Stock comp / revenue 0.8% 0.7% 36.2%

Financial Health

11 metrics
MetricECLTMOCDZI
Debt / assets 42.4% 36.2% 64.5%
Debt / equity 1.3x 0.8x 18.6x
Net debt / EBITDA 4.0x 3.1x -3.3x
Debt / FCF 7.3x 5.4x -2.8x
Liabilities / assets 66.4% 52.1% 96.5%
Equity / assets 33.6% 47.9% 3.5%
Interest coverage 8.0x 12.0x -2.8x
Current ratio 1.1x 1.8x 1.2x
Quick ratio 0.7x 1.2x 0.9x
Cash ratio 0.1x 0.4x 0.5x
Altman Z-score 4.03 4.18 -6.75

Shareholder Returns

7 metrics
MetricECLTMOCDZI
Dividend yield 0.9% 0.3% –
Net buyback yield 1.1% 1.6% –
Shareholder yield 2.0% 1.8% –
Payout ratio (earnings) 39.0% 9.5% –
Payout ratio (FCF) 45.6% 8.9% –
Dividend growth (1Y) 12.7% 8.0% –
Dividend CAGR (3Y) 9.7% 10.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusECLTMOCDZI
Forward P/E 39.1xFY2026 27.0xFY2026 –
EPS, next fiscal year $7.91FY2026 $25.92FY2026 $-0.54FY2026
EPS growth, next FY +5.0%FY2026 +13.3%FY2026 –
EPS growth, the year after +23.4% +2.2% –
Revenue, next fiscal year $17.28BFY2026 $50.12BFY2026 $8.61MFY2026
Revenue growth, next FY +7.5%FY2026 +12.5%FY2026 -47.2%FY2026
Revenue growth, the year after +5.7% -2.7% +109.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersECLTMOCDZI
Held by institutions 80.0% 90.2% 46.7%
Institutions holding 1,715 2,627 117
Change in shares held, QoQ +1.4% +0.8% +4.0%
Institutions buying 764 1,145 54
Institutions selling 680 1,145 39
Buyers to sellers 1.12 1.00 1.38

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ECLTMOCDZI
ECL 1.00 0.23 0.11
TMO 0.23 1.00 0.15
CDZI 0.11 0.15 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ECL, TMO and CDZI?

Thermo Fisher Scientific (TMO) is the largest by market capitalisation: Ecolab (ECL) $87.00B, Thermo Fisher Scientific (TMO) $258.39B, Cadiz (CDZI) $259.17M.

Which stock is cheaper, ECL, TMO and CDZI?

Thermo Fisher Scientific (TMO) trades on the lowest price-to-earnings ratio (Ecolab (ECL) 41.8x, Thermo Fisher Scientific (TMO) 36.5x, Cadiz (CDZI) -6.2x). On next year's consensus earnings, Thermo Fisher Scientific (TMO) is cheapest (Ecolab (ECL) 39.1x, Thermo Fisher Scientific (TMO) 27.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Ecolab (ECL) grew revenue fastest over the trailing twelve months: Ecolab (ECL) +9.3%, Thermo Fisher Scientific (TMO) +8.3%, Cadiz (CDZI) -21.3%.

Which company is more profitable?

Thermo Fisher Scientific (TMO) has the highest net margin (Ecolab (ECL) 12.0%, Thermo Fisher Scientific (TMO) 14.9%, Cadiz (CDZI) -353.9%). On return on invested capital, Ecolab (ECL) leads (Ecolab (ECL) 10.0%, Thermo Fisher Scientific (TMO) 8.0%, Cadiz (CDZI) -29.0%).

Which stock has performed better?

Over the past year Thermo Fisher Scientific (TMO) returned the most: Ecolab (ECL) +18.0%, Thermo Fisher Scientific (TMO) +20.7%, Cadiz (CDZI) -34.3%. Over five years, Ecolab (ECL) compounded fastest (Ecolab (ECL) +5.6%/yr, Thermo Fisher Scientific (TMO) +2.0%/yr, Cadiz (CDZI) -11.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Ecolab (ECL) has the highest dividend yield: Ecolab (ECL) 0.01%, Thermo Fisher Scientific (TMO) 0.00%, Cadiz (CDZI) 0.00%. Cadiz (CDZI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ecolab (ECL) has been the steadiest (Ecolab (ECL) 21.8%, Thermo Fisher Scientific (TMO) 30.7%, Cadiz (CDZI) 69.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ECL, TMO and CDZI?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Ecolab (ECL) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.